(Total Views: 345)
Posted On: 07/02/2025 2:28:41 PM
Post# of 154875
Re: chazzledazzle #154779
News
Article
May 16, 2025
Leronlimab Linked to Increased PD-L1 in Triple-Negative Breast Cancer
May 16, 2025
By Spencer Feldman
Fact checked by: Ryan Scott
( Leronlimab treatment was tied to an increased expression of an immune cell protein or “checkpoint inhibitor” known as programmed death-ligand 1 (“PD-L1”) on circulating tumor cells in patients with metastatic triple-negative breast cancer, according to a news release from CytoDyn Inc. In turn, this suggests a novel mechanism of action for leronlimab treatment in solid tumors )
Source read in full
https://www.curetoday.com/view/leronlimab-lin...ast-cancer
Article
May 16, 2025
Leronlimab Linked to Increased PD-L1 in Triple-Negative Breast Cancer
May 16, 2025
By Spencer Feldman
Fact checked by: Ryan Scott
( Leronlimab treatment was tied to an increased expression of an immune cell protein or “checkpoint inhibitor” known as programmed death-ligand 1 (“PD-L1”) on circulating tumor cells in patients with metastatic triple-negative breast cancer, according to a news release from CytoDyn Inc. In turn, this suggests a novel mechanism of action for leronlimab treatment in solid tumors )
Source read in full
https://www.curetoday.com/view/leronlimab-lin...ast-cancer
(5)
(0)
